OmniAb (OABI) Change in Acquisitions & Divestments (2023 - 2026)
OmniAb's (OABI) quarterly Change in Acquisitions & Divestments came in at $18.0 million in Q1 2026, up 19900.0% year-on-year from N/an in Q1 2025, and down 64.5% on a QoQ basis from $50.7 million in Q4 2025.
OmniAb (OABI) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
OmniAb (OABI) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $18.0 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 19900.0% year-over-year to $18.0 million in Q1 2026; TTM through Mar 2026 was $68.7 million, a 11.24% decrease from a year earlier, with the FY2025 full-year figure at $50.8 million, down 34.87% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $18.0 million, down from $50.7 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for OABI reached as high as $76.1 million in Q4 2024 and fell as low as -$62.8 million in Q4 2023.
- Historically, Change in Acquisitions & Divestments has averaged $11.6 million across 4 years, with a median of $4.0 million in 2023.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 174.09% in 2024 and soared 19900.0% in 2026, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at -$62.8 million in 2023, then soared by 221.13% to $76.1 million in 2024, then slumped by 33.37% to $50.7 million in 2025, then slumped by 64.5% to $18.0 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $18.0 million in Q1 2026, $50.7 million in Q4 2025, and -$27.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | OmniAb | 260.98 Mn | 211.91 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.00 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 50.71 Mn |
| Dec 31, 2025 | 50.71 Mn |
| Sep 30, 2025 | -27.21 Mn |
| Sep 30, 2025 | -27.21 Mn |
| Jun 30, 2025 | 27.21 Mn |
| Jun 30, 2025 | 27.21 Mn |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 76.10 Mn |
| Dec 31, 2024 | 76.10 Mn |
| Sep 30, 2024 | -48.60 Mn |
| Sep 30, 2024 | -48.60 Mn |
| Jun 30, 2024 | 49.82 Mn |
| Jun 30, 2024 | 49.82 Mn |
| Mar 31, 2024 | 678,000.00 |
| Mar 31, 2024 | 678,000.00 |
| Dec 31, 2023 | -62.83 Mn |
| Dec 31, 2023 | -62.83 Mn |